Protagonist Therapeutics Inc - ESG Rating & Company Profile powered by AI
This ESG score covers seventeen UN SDGs including: 'Clean Water & Sanitation', 'Reduced Inequalities' and 'Partnerships for the Goals'. Other corporations in the scoring industry group for Protagonist Therapeutics Inc are displayed. The report of Protagonist Therapeutics Inc employs intelligence from across the web as well as from available filings by Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.5; made up of an environmental score of 1.3, social score of 2.3 and governance score of 4.0.
2.5
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1481 | Tissue Regenix Group PLC | 2.6 | Medium |
| 1481 | Twist Bioscience Corp | 2.6 | Medium |
| 1499 | Protagonist Therapeutics Inc | 2.5 | Medium |
| 1499 | Akeso Inc | 2.5 | Medium |
| 1499 | Allergan plc | 2.5 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Protagonist Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Protagonist Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Protagonist Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Protagonist Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Protagonist Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Protagonist Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Protagonist Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Protagonist Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Protagonist Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Protagonist Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Protagonist Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Protagonist Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Protagonist Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Protagonist Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Protagonist Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Protagonist Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Protagonist Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Protagonist Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Protagonist Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Protagonist Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Protagonist Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Protagonist Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Protagonist Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Protagonist Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Protagonist Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Protagonist Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Protagonist Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Protagonist Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Protagonist Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Protagonist Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Protagonist Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Protagonist Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Protagonist Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Protagonist Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Protagonist Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Protagonist Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Protagonist Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with polycythemia vera and hereditary hemochromatosis, as well as for the treatment of other blood disorders; PN-943, an oral, alpha-4-beta-7 integrin- specific antagonist peptide that is in Phase II clinical trials for treating inflammatory bowel disease (IBD); and PN-235, an orally delivered interleukin-23 receptor specific antagonist for the treatment of IBD and non-IBD indications. The company has a license and collaboration agreement with Janssen Biotech, Inc. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.